TELA Bio (TELA) Return on Invested Capital (2025 - 2026)
TELA Bio (TELA) posted quarterly Return on Invested Capital of 0.1% for Q1 2026, little changed quarter-over-quarter from 0.1% in Q4 2025.
TELA Bio (TELA) Return on Invested Capital (2025 - 2026) Analysis & Trends
TELA Bio's Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.1% for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 0.01% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 0.01% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 0.00% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 0.01% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 0.00% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 0.04% |
| 10 | TELA Bio | 36.75 Mn | 6.32 Mn | 13.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.10% |
| Dec 31, 2025 | -0.10% |